
Pediatric Cancer Bill is Good News That Still Hurts
Bulwark Takes
00:00
Why pediatric cancer research lags
Sam Stein explains market incentives and why rare childhood cancers attract little pharmaceutical investment.
Play episode from 04:13
Transcript


